Amgen España
Contact details

Moll de Barcelona, s/n, Edifici World Trade Center Barcelona
08039 Barcelona (Barcelona)
Espanya
Telephone: +34 936 001 900
Fax: +34 933 019 009
comamgenspain@amgen.com
Visit Website
Contact person
Jordi Martí | jmarti@amgen.com
General information

Type of organization: Company
Founding year: 1990
Business model and activity description
Description
Amgen is a biotechnology pioneer company that discovers, develops and delivers innovative human therapeutics based on the improvements on cellular and molecular biology.
Main activities
- >> Manufacturing
- >> R&D
- >> Sales & Marketing
Main areas
- >> Biotechnology
- >> Human Health: Pharmacological or Biological Therapeutics
R&D lines
Amgen's research lines are mainly focused in oncology, hematology, kidney disease, rheumatoid arthritis and other serious illnesses.
Therapeutic areas
- >> Genitourinary system
- >> Inflammatory diseases
- >> Oncology
Results and development
Services and products
Anakinra (IL-1ra), is a recombinant form of a naturally occurring protein that regulates interleukin-1 (IL-1), that inhibits the inflammatory response in rheumatoid arthritis.
Mimpara® (Cinacalcet) lowers parathyroid hormone (PTH) release by parathyroid
Last updated
04/05/2012
The directory is an on-going process by Biocat to profile all Catalan biotech players. Despite all the efforts of having updated information, errors and omissions may occur. If your company or organization is not included or you are willing to update the data, please please fill out the form.
